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Abstract 
Various vaccine therapies for Alzheimer’s disease (AD) have been investigated. Here we 
report transgenic rice expressing amyloid β-peptide (Aβ). The Aβ42 gene fused with a green 
fluorescent protein gene was introduced into rice using the Agrobacterium method. When 
transgenic brown rice expressing Aβ was orally administered to mice, serum anti-Aβ antibody 
titers were elevated. The same results were observed when mice were fed boiled, transgenic 
brown rice. The results indicate that an edible vaccine against AD using rice may be feasible. A 
vaccine derived from rice would be far cheaper than existing medical vaccines. 
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Introduction 
Alzheimer’s  disease  (AD)  causes  cognitive  im-
pairment  and  while  symptomatic  therapies  such  as 
donepezil  hydrochloride  are  available,  no  existing 
therapeutic medication offers complete recovery from 
AD.  The  development  of  new  AD  therapies  would 
lessen the social and economic burden of the disease. 
The onset of AD is thought to be due to amyloid 
β-peptide (Aβ) deposition in the cerebral cortex [1,2]. 
As  Aβ  is  a  protein,  vaccines  for  AD  are  potential 
means of therapy or prevention [3-5]. In trials using 
mouse models of AD, injection with Aβ as an antigen 
reduced  the  level  of  Aβ  accumulation  in  the  brain 
notably, reduced memory defects and improved be-
havioral disorders [6,7]. A phase I clinical trial of vac-
cine  therapy  by  intramuscular  injection  of  Aβ  was 
completed without problems but the phase II clinical 
trial was terminated because some patients developed 
meningoencephalitis [8]. In a 6-year follow-up of pa-
tients in the trial of AD immunization [9], cortical Aβ 
loads were lower in immunized patients compared to 
the control group. Patients with higher antibody re-
sponses had more extensive  Aβ removal. However, 
this study did not find survival or time to severe de-
mentia improved in immunized patients versus the 
control group. 
A vaccine therapy with no side effects is needed. 
Oral  or  other  mucosal  vaccinations  appear  to  have 
fewer side effects than vaccines administered by in-
jection [10,11]. A potential method of oral vaccination 
is to express a target protein in an edible plant. In-
creased serum anti-Aβ antibody titer and suppressed 
Aβ deposition in the brain were observed when green 
pepper or potato containing Aβ was fed to a mouse 
model of AD [11,12,13,14]. Edible vaccine might also 
be produced in genetically modified food plants such 
as rice or soybeans that accumulate Aβ in seeds. Ce-Int. J. Biol. Sci. 2011, 7 
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real seeds are better suited for edible vaccines than 
fruit or vegetables as many have high protein content 
and can be stored for long periods at room tempera-
ture. 
In the present study, we introduced the Aβ gene 
conjugated with green fluorescent protein (GFP) into 
rice, and orally administered modified rice to mice in 
order to investigate the effects of Aβ on serum anti-Aβ 
antibody titer. 
Materials and Methods 
Plant materials 
Oryza sativa L. cultivar Hayayuki (Japonica rice 
in Japan) was used in this study. Mature seeds (brown 
rice) were sterilized in 70% ethanol for 10 s and 1% 
sodium hypochlorite for 15 min, and rinsed in sterile 
distilled water. Seeds were placed on N6D medium 
[15,16] for callus formation. Cultures were incubated 
at  25C  under  a  16-h  photoperiod  using  cool-white 
fluorescent light at 40 μmol/m2/s. Calli were isolated 
from seed scutella 10-30 days later, and used for Aβ 
gene induction. 
Plasmid construction 
The nucleoside sequence coding Aβ42 was am-
plified  by  PCR  using  primers  Aβ-5’-XhoI 
(5’-GAAGTCTCGAGTGATGCAGAAT-3’)  and 
Aβ-3’-HindIII  (5’-GAACGAAGCTTTTACGCTATGA 
CA-3’). The gene for the APP695 protein was used as a 
template.  The  product  was  digested  with  XhoI  and 
HindIII,  and  inserted  into  pEGFP-C2  (Clontech)  at 
restriction sites resulting in pEGFP-Aβ-C2. 
The nucleoside sequence coding sGFP(S65T) [17] 
was  amplified  by  PCR  using  primers  sGFP-5’-AgeI 
(5’-ATACCGGTCGCCACCATGGTGAGCAAGGGC
GAG-3’)  and  sGFP-3’-BglII  (5’-TCAGATCTGAGT 
CCGGCCGGACTTGTACAGCTCGTCCAA-3’).  The 
product was digested with AgeI and BglII, and ligated 
to the pEGFP-Aβ-C2 at the restriction sites to produce 
psGFP-Aβ-C2. The GFP-Aβ fused gene was produced 
by  amplifying  psGFP-Aβ-C2  by  PCR  using  primers 
sGFP-5’-XbaI  (5’-TTTCTAGAATGGTGAGCAAGG 
GCGAGGAG-3’)  and  Aβ-3’-SacII  (5’-TTGAGCT 
CGACTGCAGAATTCGAAGCTT-3’),  followed  by 
digestion with XbaI and SacII. 
The binary vector pIG121-Hm [18] was digested 
with XbaI and SacII to remove the Intron-Gus gene. 
The  GFP-Aβ  fused  gene  was  then  ligated  to 
pIG121-Hm to produce pIG121-Hm (sGFP+Aβ). 
The  binary  vector  pIG121-Hm  (sGFP+Aβ)  was 
electroporated  into  Agrobacterium  tumefaciens  strain 
EHA101  using  an  Escherichia  coli  pulser  (Bio-Rad). 
Transformants  EHA101  (pIG121-Hm  (sGFP+Aβ)) 
were  selected  on  LB  medium  containing  50  mg/L 
kanamycin,  50  mg/L  hygromycin  B  and  1.2%  Bac-
to-agar. 
Transformation 
EHA101  (pIG121-Hm  (sGFP+Aβ))  was  grown 
overnight on LB medium with 50 mg/L kanamycin, 
50 mg/L hygromycin, and 1.2 % Bacto-agar at 25C. 
Bacteria were suspended in AAM medium [19]. Rice 
calli were immersed in AAM medium containing the 
bacteria for 15 min. 
Calli were transferred to N6D medium, modified 
to  pH  5.2,  containing  100  μM  acetosyringone,  and 
incubated  in  the  dark  at  22C  for  3  days.  After 
co-cultivation,  calli  were  washed  with  the  medium 
(N6 salts, N6 vitamins, 2 mg/L 2,4-D, 30 g/L sucrose, 
400 mg/L carbenicillin, pH 5.8). 
Washed calli were cultured on selective media 
(N6D medium with 50 mg/L hygromycin B and 400 
mg/L carbenicillin) at 25C under a 16-h photoperiod. 
White or yellow calli were transferred every 10 days 
to the same medium. 
Calli were transferred to plant regeneration me-
dium  [20]  modified  with  100  mg/L  carbenicillin. 
Cultures were incubated at 25C under a 16-h photo-
period.  Calli  with  green  spots  or  plantlets  were 
transferred every 5-10 days, until the plantlets grew to 
more than 1 cm in height. Plantlets were transferred 
into  hormone-free  MS  medium,  and  fully  grown 
plantlets were planted in soil. 
Southern blot analysis 
  Extracted  leaf  DNA  was  digested  with  XbaI. 
Electrophoresis was performed on 1.0% agarose gels, 
and  DNAs  were  blotted  onto  a  Hybond-N+  mem-
brane (GE Healthcare) and were subjected to Southern 
hybridization.  GFP  sequence  containing  the  whole 
coding region was used as a probe. Probe labeling and 
southern  hybridization  procedures  were  performed 
using the AlkPhos direct labeling and detection sys-
tem with CDP-Star (GE Healthcare). 
Quantification of expression levels in seeds 
Frozen seeds were crushed. Total protein in one 
seed (approximately 20 mg) was extracted for 1 h with 
400 μL protein extraction buffer (20 mM Tris-HCl (pH 
6.5), 8 M urea, 5% 2-mercaptoethanol, 20% glycerol, 
4% SDS), and was centrifuged for 10 min at 20,000 × g. 
Three microliters of each supernatant was applied to 
Tris-Tricine SDS-PAGE (12% T, 3% C) together with 
Aβ (human, 1-42) (Peptide Institute) as standards, and 
the separated protein were transferred to a Hybond-P 
PVDF  membrane  (GE  Healthcare).  The  membrane 
was first incubated in blocking buffer (5% skim milk, 
T-PBS), and treated with anti-Aβ antibody 6E10 (Sig-Int. J. Biol. Sci. 2011, 7 
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net). The GFP-Aβ fusion protein bound to the mem-
brane  was  detected  using  the  HRP-conjugated  sec-
ondary antibody (GE Healthcare) and the ECL plus 
Western blotting detection system (GE Healthcare). 
Mouse immunization 
The quantity of brown rice administered to each 
mouse was adjusted to deliver 10 g of Aβ. Crushed 
brown rice was mixed with cholera toxin B (CTB, List 
Biological  Laboratories)  (5  g  per  mouse)  in  PBS. 
C57BL/6J  mice  (Charles  River)  were  divided  into 
three groups (eight mice per group) and were orally 
fed with a feeding needle (non-transgenic brown rice, 
Aβ-containing brown rice (Aβ rice), or boiled Aβ rice). 
Mice received doses of rice once a week from 8 to 11 
weeks of age. As a booster, 0.5 g of Aβ mixed with 
Freund’s incomplete adjuvant was injected subcuta-
neously into all mice at 14 weeks of age. Blood serum 
was collected at 8, 12, 14, and 16 weeks of age. Mice 
were housed at 25C with a 12-h light/dark cycle. All 
animal  procedures  were  approved  by  the  Animal 
Care and Use Committee of the National Agricultural 
Research Center for the Tohoku Region. 
Quantification of the anti-Aβ antibody titer with 
ELISA 
Micro  plate  wells  were  coated  with  Aβ42  dis-
solved  in  0.15  M  ammonium.  After  washing  with 
PBS-T, wells were blocked with blocking buffer (3% 
skim  milk,  PBS),  and  were  washed.  Blood  serum 
samples were diluted 10-50 times. Anti-Aβ antibody 
6E10 (1 mg/mL) was diluted 10,000-160,000 times as a 
positive control. Each sample was applied to a well 
and incubated at 37C for 1 h. After washing, each 
well was blocked at room temperature for 30 min with 
3% skim milk and was washed again. Wells were in-
cubated with HRP-conjugated secondary antibody at 
37C for 1 h and were washed. Wells were incubated 
with a TMB kit (Pierce) at room temperature in the 
dark. The reaction was stopped with 2 M sulfuric acid. 
Absorbance at 450 nm was measured with a spectro-
photometer (Infinite F300, Tecan), and antibody titers 
were calculated (0.1 g/mL 6E10 = 100 units/mL an-
tibody titer). 
Detection of the anti-Aβ antibody production by 
Western blot analysis 
Aβ (240 ng) was applied to l2% polyacrylamide 
gels  containing  0.l%  SDS;  separated  proteins  were 
transferred  to  a  Hybond-P  PVDF  membrane.  The 
membrane was first incubated in blocking buffer (ECL 
Advance blocking agent, GE Healthcare), and treated 
with  serum  samples  (10  times  dilution).  Anti-Aβ 
production was detected by HRP-conjugated second-
ary antibody and the ECL advance Western blotting 
detection kit (GE Healthcare). 
Results and Discussion 
Initially, the luminescence of transgenic rice ex-
pressing  the  EGFP-Aβ  fusion  gene  was  weak.  The 
sGFP(S65T) gene is designed for plant use and gives 
brighter light in the plant than the original GFP [17]. 
We therefore expressed sGFP instead of EGFP in rice, 
and  the  resulting  transgenic  rice  seeds  exhibited 
stronger  luminescence  with  many  fluorescent  spots 
(Fig. 1A, B). Fluorescence was localized mainly in the 
aleurone layer of brown rice (Fig. 1C). Polished rice 
had a little fluorescence (Fig. 1D).  
These results  show that Aβ accumulates  in al-
eurone layer, and if brown rice is polished, a propor-
tion of Aβ is removed from the rice. Most rice eaten in 
Japan is polished, and brown (non-polished) rice must 
be eaten for AD vaccination to succeed. 
The presence of the Aβ-GFP gene in the leaves of 
primary  transgenic  rice  plants  (R0  rice  plants)  was 
investigated  by  PCR  analysis  using  primers 
sGFP-5’-XbaI  and  Aβ-3’-SacII  (data  not  shown).  In 
samples where PCR analysis indicated the presence of 
the Aβ-GFP gene, Southern blot analysis was used to 
confirm transformation in individual plants (Fig. 2). 
The Aβ-GFP gene was introduced into R0 plants ex-
cept line No. 32. The positive PCR result in the Line 
No. 32 plant may have been due to residual Agrobac-
terium in plant tissue. 
Western  blotting  was  used  to  investigate  the 
accumulation  of  the  Aβ-GFP  fusion  protein  in  Aβ 
transgenic  rice  (Fig.  3).  The  signal  intensity  of  the 
band  was  compared  against  the  signal  intensity  of 
Aβ42  as  a  control,  and  differences  were  observed 
among lines. The highest concentration, 8 g of Aβ in 
a single grain of brown rice (400 μg/g brown rice) was 
found in samples from line 29, compared with 18-50 
g  Aβ  [13]  and  77  g  Aβ  [14]  per  gram  of  soluble 
protein found in potato in previous studies. 
Immunogenicity  of  Aβ  rice  was  assessed  by 
feeding brown Aβ rice to C57BL/6J mice, from 8 to 11 
weeks of age, and assessing serum anti-Aβ antibody 
titer by ELISA (Fig. 4). At 12 weeks age, we observed a 
significant increase in serum anti-Aβ antibody titer in 
mice fed boiled Aβ rice; the increase was not signifi-
cant in mice fed uncooked Aβ rice. Anti-Aβ antibody 
was also detected by Western blot analysis in mice fed 
Aβ rice (Fig. 4B). No increase of anti-Aβ antibody titer 
was detected in mice at 14 weeks of age, three weeks 
after  the  last  oral  administration  (Fig.  4C);  but  the 
anti-Aβ antibody titer significantly increased again at 
16 weeks of age, after a subcutaneous booster injection 
(Fig. 4D). Int. J. Biol. Sci. 2011, 7 
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Fig. 1. Detection of GFP fluorescence in seeds (brown rice). (A) Transgenic brown rice (upper seed) and non-transgenic 
brown rice (lower seed). (B) Transverse sections of transgenic brown rice (upper seed) and non-transgenic brown rice 
(lower seed). (C) Aleurone layer in transverse section of transgenic brown rice. Right panel shows fluorescence view. Bar 
indicates 200 μm. Arrows show aleurone layer. (D) Effects of polishing transgenic brown rice: non-polished rice (left seed, 
weight: 21.3 mg), the roughly polished rice (middle seed), and the polished rice (right seed, weight: 19.1 mg, rice-polishing 
rate: 89.3%). The yellow region of roughly polished rice is bran layer. A fluorescence stereo-microscope (Nikon SMZ800) 
was used to observe GFP fluorescence. 
   
Fig. 2. Southern blot analysis of Xba I-digested total DNA probed for GFP-specific genes. WT, non-transgenic rice plant: R0, 
primary transgenic rice plant.  
B A C
D
Line No. WT     1      4      29     32     37      57
6 kbp
10 kbp
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Transgenic rice (R0 generation)Int. J. Biol. Sci. 2011, 7 
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Fig. 3. Determination of Aβ42 expression levels. Brown rice samples were subjected to SDS-PAGE with Aβ42 at increasing 
concentration (5, 10, 20, 40 and 60 ng). Approximately 0.15 mg of crushed seeds was applied to each lane. R0 seeds (R1 
generation) and R1 seeds (R2 generation) were used. WT; non-transgenic rice; R1, R0 progeny; R2, R1 progeny. Faint band in 
WT is non-specific band just below Aβ42 band. 
 
 
 
Fig.  4.  Titers  of  antibodies  against  Aβ  in  serum  from  8-week-old  mice  before  immunization  (A),  12-week-old  and 
14-week-old mice after immunization (B, C, each), and 16-week-old mice after booster injection (D). Anti-Aβ antibody 
titers for each mouse are shown. Horizontal lines show average.* P < 0.05 vs. control. Data were compared by t-test after 
logarithmic conversion. Antibody production evaluated by Western blot analysis (B). For each group, four serum samples 
with highest anti-Aβ antibody titers were mixed and used for Western blot analysis. 
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The  increase  of  anti-Aβ  antibody  titer  after 
booster injection shows the presence of anti-Aβ anti-
body response in mice fed uncooked Aβ rice or boiled 
Aβ rice. However, the increase in anti-Aβ antibody 
titer at 12 weeks of age shows the booster injection 
was not necessary for Aβ oral immunization. 
In  a  previous  study  using  green  pepper  con-
taining Aβ [11], we examined the effect on anti-Aβ 
antibody titers of orally immunized mice and subcu-
taneously  immunized  mice  over  a  long-term  (12.5 
months) trial. The increases in anti-Aβ antibody titer 
of orally immunized mice were similar to increases in 
injected mice. In the present study, the increases in 
anti-Aβ antibody titers of mice fed Aβ rice were not as 
great as those observed in mice given a booster injec-
tion.  The  difference  between  the  studies  may  arise 
from the differences in the period of antigen admin-
istration.  Further,  even  if  an  antibody  response  is 
weak,  Aβ  in  mice  brains  may  be  removed  by 
long-term  immunization  of  the  AD  mouse  models 
[21]. Taken together, we conclude that long-term oral 
administration  of  Aβ  rice  without  Aβ  injection  can 
prevent and treat AD in mice. 
In  general,  the  immunological  effect  after 
oral-intestinal  mucosal  immunization  tends  to  be 
weak,  and  this  method  may  induce  immunological 
tolerance. Oral immunological tolerance can be sup-
pressed  by  the  use  of  specific  adjuvants.  Bacterial 
toxin, such as CTB, is often used as an adjuvant in oral 
immunization  of  mice.  Although  CTB  may  not  be 
highly toxic, there may be some clinical side effects. A 
safer adjuvant might be developed from plants that 
produce compounds such as saponin [22] and it may 
be feasible to develop adjuvant-free oral vaccine from 
plants. Further animal study is necessary to determine 
the effectiveness of adjuvant-free A rice for AD. 
In a previous study, we developed a technique in 
which  a  plant  (green  pepper)  was  infected  with  a 
plant  virus,  causing  Aβ  to  accumulate  within  the 
plant  [12].  Mice  that  were  orally  administered 
Aβ-containing  plant  tissue  showed  lower  levels  of 
serum  IgG2a,  an  inflammatory  Th1  immunological 
globulin, than mice in which the vaccine was admin-
istered by injection [11]. These results indicate that the 
plant-derived vaccine  is safe and effective. In addi-
tion,  vaccines  made  using  plants  are  far  safer  than 
vaccines from animal cells or microbes as there is less 
danger  of  the  vaccine  being  adulterated  with  prion 
proteins, pathogenic viruses, or bacterial toxins. Thus, 
plant-derived vaccines require less purification, and 
may be produced cheaply. 
The rice cultivar ‘Hayayuki’ used in this study is 
an  early-ripening  variety  that  can  be  harvested  ap-
proximately  3  months  after  planting.  Moreover,  its 
compact  form  allows  year-round  production  in  a 
greenhouse  or  plant  factory  so  that  transgenic  rice 
would  be  easily  contained.  The  additional  cost  of 
contained production is likely to be justified by a high 
added-value product, such as a remedy for AD. 
In the present study,  we showed that  oral ad-
ministration of Aβ rice to mice elevated serum An-
ti-Aβ  antibody  titer.  We  previously  found  oral  ad-
ministration  of  Aβ  green  pepper  to  Tg2576  mouse 
models  elevated  serum  Anti-Aβ  antibody  titer  and 
reduced senile plaques; and that there was an inverse 
correlation between anti-Aβ antibody titers and solu-
ble intracerebral Aβ [11]. It is likely that accumulation 
of Aβ in the brain can be suppressed by administering 
Aβ rice. We plan a further experiment with AD mouse 
models to investigate whether oral immunization by 
long-term administration of Aβ rice decreases senile 
plaques. 
Rice is commonly eaten in grain form without 
first  being  pulverized.  This  would  make  it  easy  to 
control intake, as with medicines in pill form. In ad-
dition, where rice is eaten as a staple, it is possible to 
ensure  regular  intake.  In  the  present  study,  we 
showed that boiled Aβ rice does not reduce the effi-
cacy of the vaccine, thereby allowing its use as an ed-
ible vaccine. The ease of use of an Aβ rice vaccine for 
AD  makes  this  the  most  attractive  vaccine  for  pre-
venting and treating the disease. 
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